tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of John Hsu, 13 are a BUY (100%).
Analyst John Hsu, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 100% that have a potential upside of 19.33% achieved within 265 days. Previously, John Hsu worked at CREDIT SUISSE.
John Hsu’s has documented 23 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QDEL, Quidel at 19-Mar-2020.
Analyst best performing recommendations are on NEO (NEOGENOMICS).
The best stock recommendation documented was for NEO (NEOGENOMICS) at 10/23/2018. The price target of $16 was fulfilled within 7 days with a profit of $2.01 (14.37%) receiving and performance score of 20.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Nov-2022
$74
$10 (15.63%)
$60
27 days ago
(24-Sep-2026)
9/10 (90%)
$12.63 (20.58%)
229
Hold Since 09-Aug-2023
$46
$-18 (-28.13%)
$25
2 months 20 days ago
(31-Jul-2026)
11/11 (100%)
$2.29 (5.24%)
232
Hold Since 15-Dec-2025
$21
$-7.82 (-27.13%)
$18
7 months 26 days ago
(25-Feb-2026)
4/4 (100%)
$2.54 (13.76%)
32
Buy Since 08-Oct-2024
$22
$-6.82 (-23.66%)
$22
1 years 28 days ago
(23-Sep-2025)
5/11 (45.45%)
$6.43 (41.30%)
130
Buy Since 17-Apr-2024
$40
$11.18 (38.79%)
$40
1 years 5 months 16 days ago
(05-May-2025)
0/3 (0%)
$24.83 (163.68%)
What Year was the first public recommendation made by John Hsu?
